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        Introduction 
  Small ubiquitin-like modifi  er proteins (SUMOs) are ubiquitin-
related proteins that act in many processes through covalent 
linkage to cellular proteins (  Johnson, 2004  ). Mammalian cells 
express three major SUMO paralogues: mature SUMO-2 and 
SUMO-3 are     95% identical to each other and each is    45% 
identical to SUMO-1. (Where they cannot be distinguished, 
SUMO-2 and -3 will be collectively called SUMO-2/3.) SUMO-1 
localizes within the nucleoplasm, nuclear envelope, and nucleo-
lus, whereas SUMO-2 and SUMO-3 are predominantly found 
in the nucleoplasm (  Ayaydin and Dasso, 2004  ). All newly 
synthesized SUMOs are processed by ubiquitin-like protein/
sentrin-specifi  c proteases (Ulp/SENPs), and Ulp/SENPs also 
deconjugate SUMOylated species (  Hay, 2007  ;   Mukhopadhyay 
and Dasso, 2007  ).   Saccharomyces cerevisiae   has two Ulp/
SENPs, Ulp1p and Ulp2p (  Li and Hochstrasser, 1999  ,   2000  ). 
Ulp1p is essential and localizes to nuclear pores, whereas Ulp2p 
is dispensable for growth and localizes to the nucleoplasm. 
Ulp1p has been particularly implicated in ribosome biogenesis 
(  Panse et al., 2006  ). 
  The nucleolus is the site of ribosome synthesis, including 
preribosomal RNA transcription, ribosomal RNA (rRNA) pro-
cessing, and ribosomal subunit assembly (  Boisvert et al., 2007  ). 
B23/nucleophosmin is an abundant 37-kD phosphoprotein that 
shuttles between the granular component of the nucleolus and 
cytoplasm. B23/nucleophosmin can become SUMO conjugated 
under some circumstances (  Liu et al., 2007  ). It has been impli-
cated in many cellular processes, including ribosome biogenesis 
and export, centrosome duplication, and maintenance of ge-
nomic integrity through the Arf – MDM2 – p53 pathway ( Grisendi 
et al., 2006  ;   Sherr, 2006  ). Consistent with these diverse roles, 
U
biquitin-like protein/sentrin-speciﬁ   c proteases 
(Ulp/SENPs) mediate both processing and de-
conjugation of small ubiquitin-like modiﬁ  er pro-
teins (SUMOs). Here, we show that Ulp/SENP family 
members SENP3 and SENP5 localize within the granular 
component of the nucleolus, a subnucleolar compartment 
that contains B23/nucleophosmin. B23/nucleophosmin is 
an abundant shuttling phosphoprotein, which plays im-
portant roles in ribosome biogenesis and which has been 
strongly implicated in hematopoietic malignancies. More-
over, we found that B23/nucleophosmin binds SENP3 
and SENP5 in   Xenopus laevis   egg extracts and that it is 
essential for stable accumulation of SENP3 and SENP5 in 
mammalian tissue culture cells. After either codepletion of 
SENP3 and SENP5 or depletion of B23/nucleophosmin, 
we observed accumulation of SUMO proteins within nu-
cleoli. Finally, depletion of these Ulp/SENPs causes de-
fects in ribosome biogenesis reminiscent of phenotypes 
observed in the absence of B23/nucleophosmin. Together, 
these results suggest that regulation of SUMO deconjuga-
tion may be a major facet of B23/nucleophosmin function 
in vivo.
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granular component (dsRed-B23/nucleophosmin). The signal 
from GFP-SENP3 and GFP-SENP5 overlapped poorly with 
UBF staining and only partially with dsRed-fi  brillarin, suggest-
ing that they were not concentrated in either the fi  brillar centers 
or the dense fi  brillar component (  Fig. 1 A  , top). In contrast, both 
proteins showed distributions that were very similar to B23/
nucleophosmin, which could be observed either by immuno-
staining or by coexpression of B23/nucleophosmin as a fusion 
with the dsRed fl  uorescent protein (  Fig. 1 A  , bottom). We con-
clude that SENP3 and SENP5 are concentrated within the gran-
ular component. 
  The presence of SUMO-2/3  –  specifi  c proteases within nu-
cleoli suggested that the absence of these SUMO paralogues 
might be the result of their ongoing removal from nucleolar tar-
gets. To test this idea, we depleted SENP3 and SENP5 individu-
ally and together by oligonucleotide-mediated RNA interference 
(RNAi) from HeLa cells (  Fig. 2 A  ). Depletion of either protease 
did not substantially alter the distribution of SUMO proteins. 
However, nucleolar SUMO-1 increased after codepletion of 
SENP3 and SENP5 (  Fig. 2 B   and Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200807185/DC1). Signifi  cantly, 
SUMO-2/3 also became concentrated within nucleoli in the ab-
sence of both enzymes. The redistribution of SUMO-2/3 was 
striking because these paralogues are normally not evident within 
nucleoli. Depletion of nuclear pore – associated SENP/Ulps (SENP1 
and SENP2) did not increase nucleolar levels of SUMO pro-
teins (unpublished data), arguing that such accumulation is not 
a general result of SUMO pathway manipulation or of RNAi 
machinery activation. 
  SENP3 and SENP5 show robust enzymatic activities 
against SUMO-2/3  –  containing substrates (  Di Bacco et al., 2006  ; 
B23/nucleophosmin binds to nucleic acids, nucleolar compo-
nents, transcription factors, and histones, as well as to proteins 
involved in cell proliferation, mitosis, and oncogenic stress re-
sponses (  Grisendi et al., 2006  ). It is not clear how these aspects 
of B23/nucleophosmin may be integrated with each other. 
Notably, B23/nucleophosmin is often overexpressed in solid 
tumors and has been strongly linked to hematopoietic malignan-
cies (  Grisendi et al., 2006  ). 
  We have examined the subnucleolar localization, behav-
ior, and function of two nucleolar Ulp1p-like SUMO proteases, 
SENP3 and SENP5 (  Di Bacco et al., 2006  ;   Gong and Yeh, 2006  ; 
  Mukhopadhyay and Dasso, 2007  ). We found that both of these 
enzymes colocalize and physically interact with B23/nucleo-
phosmin. Moreover, B23/nucleophosmin is essential for their 
stable accumulation. After either codepletion of these Ulp/SENPs 
or depletion of B23/nucleophosmin, SUMO proteins accrue within 
nucleoli. Importantly, depletion of SENP3 and SENP5 causes 
defects in ribosome biogenesis reminiscent of those observed in 
the absence of B23/nucleophosmin. Collectively, our fi  ndings 
indicate that regulation of SUMO deconjugation through SENP3 
and SENP5 may be a major facet of B23/nucleophosmin func-
tion and suggest that at least some of the diverse phenotypes 
found after disruption of B23/nucleophosmin can be attributed 
to defects of SUMOylation. 
  Results and discussion 
  We compared the localization of stably expressed GFP-SENP3 
and GFP-SENP5 with components that are characteristic of 
nucleolar subcompartments, including the fi  brillar centers (anti-
UBF), the dense fi  brillar component (dsRed-fi  brillarin), and the 
  Figure 1.       SENP3 and SENP5 colocalize and 
associate with B23/nucleophosmin.   (A) U2OS-
derived cell lines expressing GFP-SENP3 and 
GFP-SENP5 were transfected with a plasmid 
for expression of dsRed-ﬁ   brillarin (top). After 
48 h, the cells were ﬁ  xed and immunostained 
with monoclonal anti-UBF antibodies. The left 
column shows GFP, dsRed, and anti-UBF in the 
context of the nucleus, with DNA stained in 
blue using Hoechst 33342. The same cells 
were transfected with dsRed-B23/nucleophosmin 
(bottom). (B) Rabbit IgG (IgG), anti-xSENP3, 
or anti-xB23/nucleophosmin (xB23/NPM) anti-
bodies were used for immunoprecipitation from 
100   μ  l of interphase XEE (top). The samples 
were subjected to SDS-PAGE and immuno-
blotting with anti-xSENP3 or anti-B23/nucleo-
phosmin antibodies. To test xSENP5 binding to 
xB23/nucleophosmin, 25   μ  l of XEE containing 
in vitro  –  translated FLAG-tagged xSENP5 was 
mixed with equal volume of interphase XEE. 
Immunoprecipitations were performed with anti-
FLAG or anti-xB23/NPM antibodies (bottom). 
The samples were subjected to immunoblotting 
with anti-FLAG or anti-xB23/NPM antibodies. 
(C) Anti-xSENP3 was used for immunoprecipi-
tation from IgG-treated control (+) or xB23/
NPM-depleted (    ) XEEs. The samples were 
subjected to SDS-PAGE and Western blotting 
with anti-xSENP3, -Rpl26, -RplP0, or -xB23/
NPM antibodies, as indicated on the right.     591 B23/NUCLEOPHOSMIN REGULATES SENP3 AND SENP5   • Yun et al. 
that defects in ribosome biogenesis were specifi  cally caused 
by depletion of SENP3 and SENP5. Our results show that 
SENP3 and SENP5 individually play important roles in ribo-
some biogenesis (  Fig. 3  ), but depletion of both proteases is re-
quired for elevation of SUMO-conjugated species within nucleoli 
( Fig.  2 ).  Together,  these results might suggest that although both 
SENP3 and SENP5 can act on the bulk of nucleolar substrates, 
they may each specifi  cally regulate a subset of conjugates that 
are critical for particular events in the biogenesis pathway. 
  We were unable to extract SENP3 and SENP5 from mam-
malian nucleoli under conditions that would allow analysis of 
protein  –  protein interactions. As an alternative, we used   Xenopus 
laevis   egg extracts (XEEs) to look for binding partners. XEEs 
offer major advantages for these experiments because most nu-
clear and nucleolar proteins are stored in soluble forms (  Powers 
et al., 2001  ). Human SENP3 and   Xenopus   SENP3 (xSENP3) 
proteins are     85% identical within their catalytic domains and 
50% identical throughout their entire sequences. Human SENP5 
and xSENP5 proteins are     87% identical within their catalytic 
domains and 43% identical throughout their entire sequences. 
There was little xSENP5 in   Xenopus   eggs  (unpublished  data), 
which is perhaps consistent with the more specialized tissue dis-
tribution of mammalian SENP5 (Fig. S2 C). Antibodies against 
xSENP3 recognized a protein of the appropriate size in XEEs. 
Analysis using vinyl sulfone derivatives of different SUMO para-
logues demonstrated that xSENP3 shared the same enzymatic 
specifi  city as mammalian SENP3 (Fig. S2 D). 
  We observed a protein that strongly and specifi  cally co-
precipitated with xSENP3, which mass spectrometric analysis 
revealed to be the   Xenopus   homologue of B23/nucleophosmin 
(xB23/nucleophosmin). We confi  rmed this interaction by West-
ern blotting of anti-xSENP3 immunoprecipitates (  Fig. 1 B  ). 
Given the low levels of xSENP5 within XEEs, we used an alter-
native strategy to determine whether SENP5 might likewise 
 Gong  and Yeh, 2006  ; Fig. S2, available at http://www.jcb.org/cgi/
content/full/jcb.200807185/DC1), so they may directly control the 
half-lives of nucleolar SUMO-2/3  –  conjugated species. The func-
tions of SENP3 and SENP5 appear to be at least partially redun-
dant because high levels of SUMO-2/3 did not accumulate unless 
both proteins were depleted. Their role in controlling nucleolar 
SUMO-1 accumulation is somewhat harder to understand. It is 
possible that deconjugation of multiple SUMO moieties from some 
targets must occur in a particular sequence, so that failure to re-
move SUMO-2/3 in the absence of SENP3 and SENP5 might 
block subsequent removal of SUMO-1, and thus indirectly re-
sult in its nucleolar accumulation. Alternatively, SENP3 and 
SENP5 may be more active in vivo against SUMO-1  –  conjugated 
species than indicated by in vitro assays. 
  Budding yeast Ulp1p is required for 60S preribosome 
maturation and export (  Panse et al., 2006  ). To test whether 
SENP3 and SENP5 are similarly required, we examined rRNA 
synthesis and processing through pulse-chase analysis with 
[ 
3  H]uridine (  Fig. 3  ). Although 47S rRNA transcription was not 
substantially decreased after SENP3 depletion, the production of 
28S rRNA from their 32S precursor RNA was inhibited. After a 
2-h chase, control cells showed a ratio of labeled 32S versus 28S 
RNAs that was less than 0.5:1, whereas this ratio was over 2:1 in 
SENP3-depleted cells ( Fig. 3 B ). In contrast, loss of SENP5 did not 
have a strong effect on rRNA processing, but caused the levels of 
47S RNA transcription to drop by   >  60% (  Fig. 3 C  ). Cells depleted 
of both proteins showed both decreased 47S RNA precursor levels 
and increased 32S/28S ratios. Relocalization of ribosomal assembly 
factors further suggested disruption of ribosome biogenesis in the 
absence of SENP3 and SENP5 (Fig. S3, available at http://www.
jcb.org/cgi/content/full/jcb.200807185/DC1). Simultaneous deple-
tion of SENP1 and SENP2 marginally reduced 47S RNA transcrip-
tion but did not appreciably alter the rate of rRNA processing or 
alter assembly factor localization (unpublished data), arguing 
  Figure 2.       SENP3 and SENP5 codepletion cause 
nucleolar SUMO protein accumulation.   (A) HeLa cells 
were transfected with siRNAs directed against SENP3 
and SENP5, either singly or in combination. 72 h af-
ter transfection, depletion was conﬁ  rmed by Western 
blotting. (B) Cells depleted of SENP3, SENP5, or both 
proteins were stained with antibodies against B23/
nucleophosmin (B23; red) and either SUMO-1 (left; 
green) or SUMO-2/3 (right; green).     JCB • VOLUME 183 • NUMBER 4 • 2008  592
tion and phenotypic similarities, lead us to further examine their 
relationship. Both SENP3 and SENP5 levels decreased dramat-
ically after RNAi-mediated depletion of B23/nucleophosmin 
(  Fig. 4  ). This could be observed either by immunoblotting 
( Fig.  4 A ) or  by examination of GFP fl  uorescence in U2OS cells sta-
bly expressing GFP-SENP3 or GFP-SENP5 ( Fig. 4 B ). SENP1 
and SENP2 levels did not change after B23/nucleophosmin 
depletion (  Fig. 4 A  ). As in experiments where SENP3 and SENP5 
were codepleted (  Fig. 2  ), depletion of B23/nucleophosmin caused 
a shift of SUMO protein distribution toward nucleoli (  Fig. 4 C  ). 
Our fi  ndings suggest that B23/nucleophosmin physically inter-
acts with SENP3 and SENP5 and regulates their abundance and 
that it thus plays a critical role in controlling the profi  le of SUMO 
conjugates within nucleoli through SENP3 and SENP5. 
  Several observations indicated that SENP3 and SENP5 
loss was caused by increased degradation rather than decreased 
expression. First, GFP-SENP3 and GFP-SENP5 were not tran-
scribed from the native SENP3 and SENP5 promoters, so the 
drop in their levels upon B23/nucleophosmin depletion (  Fig. 4 B  ) 
argues that repression of those promoters cannot account for 
changes in protein levels. Second, the concentrations of SENP3 
and SENP5 mRNAs were not substantially altered by B23/
nucleophosmin depletion in HeLa cells, as measured by RT-PCR 
(unpublished data), further arguing against B23/nucleophosmin 
control of SENP3 and SENP5 transcription or mRNA stability. 
Third, B23/nucleophosmin-depleted cells did not show a sub-
stantial drop in overall protein translation, as measured by incor-
poration of [ 
35  S]methionine (unpublished data), indicating that 
preexisting ribosomes were largely suffi  cient to maintain pro-
tein synthesis levels. Notably, depletion of a key ribosomal as-
sembly factor, Rrp9 (  Venema et al., 2000  ), did not destabilize 
SENP3 and SENP5 or cause substantial nucleolar accumulation 
of SUMO proteins (unpublished data), demonstrating that their 
loss was not a simple consequence of ribosome synthesis in-
hibition but may be more specifi  cally linked to the function of 
B23/nucleophosmin. 
  Finally, SENP3 and SENP5 levels in B23/nucleophosmin-
depleted cells showed substantial, albeit incomplete, recovery 
upon treatment with the proteasome inhibitor MG132, which is 
consistent with the notion that they are subject to degradation in 
the absence of B23/nucleophosmin (  Fig. 4 D  ). Stable cell lines 
expressing GFP-SENP3 and SENP5 showed a partial redistri-
bution of GFP signals after B23/nucleophosmin depletion and 
MG132 treatment, with an increase in the ratio of nucleoplasmic 
to nucleolar distribution of both fusion proteins (unpublished 
data). This observation might indicate a role for B23/nucleo-
phosmin in retention of these Ulp/SENPs within the nucleolus. 
However, we noted that the distribution of many other nucleolar 
proteins was rearranged after MG132 treatment, so it is also pos-
sible that relocalization of GFP-SENP3 and GFP-SENP5 may 
refl  ect alterations of nucleolar structure. 
 We hypothesized that failure to deconjugate some SUMO 
species might disrupt ribosome biogenesis in the absence of 
SENP3 and SENP5. We therefore examined the SUMOylation 
of mammalian homologues of ribosomal proteins or ribosome 
assembly factors that have been implicated as SUMO conju-
gation targets in yeast (  Panse et al., 2004  ,   2006  ;   Wohlschlegel 
associate with xB23/nucleophosmin. FLAG-tagged xSENP5 was 
translated within XEEs (  Boyarchuk et al., 2007  ), followed by 
precipitation with anti-FLAG or anti-xB23/nucleophosmin 
antibodies. Like xSENP3, we found that FLAG-tagged xSENP5 
strongly bound with xB23/nucleophosmin in XEEs (  Fig. 1 B  ). 
  Mammalian cells lacking B23/nucleophosmin show de-
fects in ribosome biogenesis and particularly in 32S to 28S RNA 
processing (  Itahana et al., 2003  ). The association of B23/nu-
cleophosmin and nucleolar SENPs, as well as their colocaliza-
  Figure 3.       Depletion of SENP3 or SENP5 cause defects in ribosome bio-
genesis.   (A) HeLa cells were transfected with control oligonucleotides (Con-
trol) or siRNAs directed against SENP3 (    SENP3) and SENP5 (    SENP5) 
or both SENP3 and SENP5 (    SENP3/5). 72 h later, the cells were pulsed 
with [ 
3  H]uridine for 25 min, followed by washing and incubation with fresh 
media supplemented with 1 mg/ml of cold uridine for the indicated times 
(in hours). At each time point, equal numbers of cells were harvested for 
analysis of rRNA synthesis and processing. (Bottom) Western blots of cell 
extracts to monitor SENP3 and SENP5 and Western blotting of actin as a 
loading control. Ethidium bromide staining shows the amount of total RNA 
loaded in each lane. (B) The amounts of 28S and 32S RNAs were quan-
titated within three independent experiments as in A after 2 h. Ratios of 
32S to 28S RNAs were calculated for each experiment. Bars represent the 
mean values calculated from the three experiments   ±   SD. (C) The amount 
of 47S pre-rRNA transcript was quantitated at the initiation of the chase 
period (0 h) within three independent experiments as in A and normalized 
to the levels found in cells treated with control oligonucleotides. Bars repre-
sent the mean of normalized values from the three experiments   ±   SD.     593 B23/NUCLEOPHOSMIN REGULATES SENP3 AND SENP5   • Yun et al. 
argued that SENP3 acts upstream of B23/nucleophosmin, causing 
inhibition of ribosome biogenesis through increased B23/nucleo-
phosmin SUMOylation. In our hands, depletion of SENP3 and 
SENP5 by RNAi, either singly (not depicted) or in combination 
(  Fig. 5  ), did not cause a substantial SUMOylation of B23/nucleo-
phosmin. We do not know why our results differ from those of 
et al., 2004  ;   Denison et al., 2005  ;   Hannich et al., 2005  ). Using 
cells that stably expressed His  6  -tagged SUMO-1 (His-SUMO1F) 
or SUMO-2 (His-SUMO2F) proproteins, we examined changes 
in electrophoretic mobility of potential conjugation targets 
by Western blotting after codepletion of SENP3 and SENP5. 
We also purifi  ed the SUMO-conjugated fraction from each cell line 
by affi  nity chromatography and examined whether SUMOylated 
forms of the proteins could be found by Western analysis. 
  A subset of proteins showed clearly altered SUMOylation 
patterns under these circumstances: GNL2, the mammalian 
homologue of a 60S preribosomal export factor, showed a super-
shifted form upon depletion of SENP3/5 (  Fig. 5  ), which was 
verifi  ed as a SUMOylated form through its preferential retention 
on nickel  –  nitrilotriacetic acid (Ni-NTA) agarose beads. We ob-
served a supershifted form of the 60S ribosomal subunit RPL37A 
that was retained on Ni-NTA agarose beads in the absence of 
SENP3/5 (  Fig. 5  , top), suggesting that it was likewise subject to 
enhanced modifi  cation. Other nucleolar proteins (fi  brillarin, 
DDX3, DDX17, and NVL2; unpublished data) did not show evi-
dence of SUMOylation in this assay. Although this is an in-
complete survey of potential conjugation targets within the 60S 
ribosomal biogenesis pathway, it demonstrates that multiple path-
way components are SUMOylation targets, as in yeast. More 
importantly, enhanced RPL37A and GNL2 SUMOylation after 
depletion of SENP3 and SENP5 implicates these proteases in 
the control of ribosome biogenesis through this modifi  cation. 
  While this manuscript was under revision,   Haindl et al. 
(2008)   reported that SENP3 and B23/nucleophosmin physically 
interact and that loss of SENP3 disrupts rRNA processing. They 
  Figure 4.       B23/nucleophosmin regulates SENP3 and SENP5 abundance.   (A) HeLa cells were transfected with control oligonucleotides (left lane), siRNAs for 
codepletion of SENP1 and SENP2 (second lane), siRNAs for codepletion of SENP3 and SENP5 (third lane), or siRNAs for depletion of B23/nucleophosmin 
(right lane). After 72 h, the cells were harvested and immunoblotted with the indicated antibodies, where actin serves as a loading control. (B) U2OS cells 
stably expressing either GFP-SENP3 (top) or GFP-SENP5 (bottom) were transfected with control or B23/nucleophosmin siRNA, as indicated. After 72 h, 
the cells were washed and ﬁ  xed with 4% paraformaldehyde and stained with antibodies against B23/nucleophosmin (red). Signals from the GFP-SENP3 
and GFP-SENP5 fusion proteins are shown in green. (C) As in A, HeLa cells were transfected with control oligonucleotides or with siRNAs for depletion 
of B23/nucleophosmin. After 72 h, the cells were stained with antibodies against B23/nucleophosmin (red) and against either SUMO-1 or SUMO-2/3 
(green), as indicated. (D) 48 h after transfection with control or B23/nucleophosmin siRNAs, HeLa cells were treated for 6 h with 20   μ  M of proteasome 
inhibitor MG132 (+) or DMSO (    ). The cells were harvested and subjected to Western blotting analysis with antibodies against SENP3, SENP5, B23/
nucleophosmin, and actin, as indicated.     
  Figure 5.       Enhanced SUMO modiﬁ  cation of RPL37A and GNL2 after deple-
tion of SENP3 and SENP5.   U2OS stably expressing full-length His-tagged 
versions of SUMO-1 and SUMO-2 (His-SUMO1F and His-SUMO2F) were 
transfected with siRNAs for codepletion of SENP3 and SENP5 or with 
control oligonucleotides. After 72 h, the cells were harvested and His  6  -
SUMO  –  modiﬁ  ed proteins were isolated. Total cell extracts and His  6   afﬁ  n-
ity fractions were analyzed by Western blotting with antibodies against 
RPL37A (top), GNL2 (middle), or B23/nucleophosmin (bottom).     JCB • VOLUME 183 • NUMBER 4 • 2008  594
of pET-30a vector, respectively. xSENP3 (amino acids 327  –  615) and the 
complete coding sequence of xB23/nucleophosmin were subcloned into 
the BamHI  –  SalI sites of pET28a. Recombinant fusions encoded by these 
cDNAs were expressed in   Escherichia coli   (BL21[DE3]) and puriﬁ  ed over 
Ni-NTA agarose beads. Polyclonal antibodies against human SENP3 
and SEN5 and against xSENP3 were generated in rabbits (Covance). 
Anti-xB23/nucleophosmin antibodies were generated in rabbits (Paciﬁ  c 
Immunology). In all cases, antisera were puriﬁ  ed using antigens coupled to 
NHS-activated Sepharose 4 Fast Flow beads (GE Healthcare). 
  Cell culture, stable cell lines, and siRNA treatment 
  HeLa and U2OS cells were grown at 37  °  C, in a humidiﬁ  ed atmosphere of 
5% CO  2   in DME supplemented with 2 mM glutamine, 10% fetal bovine 
serum, and antibiotics. U2OS cells were transfected with plasmids for GFP-
SENP3 or GFP-SENP5 using Effectene reagent, and stable cell lines were 
selected and maintained with medium containing 0.5 mg/ml geneticin. 
siRNAs were transfected into HeLa cells using Oligofectamine. 
  Detection of SUMO-modiﬁ  ed substrates 
  Analysis of SUMOylated substrates (  Fig. 5  ) was performed as described 
previously (  Rodriguez et al., 1999  ). In brief, U2OS-derived cells stably ex-
pressing His  6  -tagged full-length SUMO-1 (His-SUMO1F) or SUMO-2 (His-
SUMO2F) were depleted of SENP3 and SENP5 by siRNA. 72 h later, the 
cells were harvested, lysed in lysis buffer (6 M guanidine-HCl, 0.1 M 
Na  2  HPO  4  /NaH  2  PO  4  , 0.01 M Tris-HCl, pH. 8.0, and 10 mM     -mercapto-
ethanol) plus 5 mM imidazole. After sonication, total cell lysates were 
mixed with 50   μ  l of (Ni-NTA) agarose beads and incubated for 2 h at 
23  °  C. The beads were washed with lysis buffer, followed by buffer A (8 M 
Urea, 0.1 M Na  2  HPO  4  /NaH  2  PO  4  , 0.01 M Tris-HCl, pH. 8.0, 10 mM 
    -mercaptoethanol, and 0.2% Triton X-100). After washing, the beads 
were eluted with 200 mM imidazole in 5% SDS, 0.15 M Tris-HCl, pH 6.7, 
30% glycerol, and 0.72 M     -mercaptoethanol. The eluted fraction was 
subjected to SDS-PAGE and Western blotting with anti-RPA37A, -GNL2, or 
-B23/nucleophosmin antibodies. 
  Interactions of B23/nucleophosmin with SENP3 or SENP5 
  Interphase XEEs were prepared as described previously (  Orjalo et al., 
2006  ). For   Fig. 1 B   (top), anti-xSENP3 and -xB23 antibodies or rabbit IgG 
were conjugated to protein A Dynabeads (Invitrogen). The XEE was supple-
mented with 10   μ  g/ml each of leupeptin, pepstatin, and chymostatin and 
with 20   μ  M Ran-Q69L (  Orjalo et al., 2006  ) and incubated with antibody-
coated beads for 1 h at 23  °  C. The beads were washed with buffer A (250 
mM sucrose, 2.5 mM MgCl  2  , 1 mM DTT, 100 mM KCl, and 10 mM Hepes, 
pH 7.7) plus 0.00001% digitonin and protease inhibitors and eluted with 
25   μ  l of 0.1 M glycine, pH 2.3. For   Fig. 1 B   (bottom), pT7-FLAG-TR    -
xSENP5 mRNA was made using an mMessage mMACHINE T7 kit (Ap-
plied Biosystems) and translated in XEEs (  Boyarchuk et al., 2007  ). 25   μ  l 
of the reaction was mixed with 25   μ  l of interphase XEE and 20   μ  M 
Ran-Q69L. The mixture was diluted 10-fold with buffer B (250 mM sucrose, 
2.5 mM MgCl  2  , 1 mM DTT, 50 mM KCl, 100 mM Hepes, pH 7.7, and 
0.00001% digitonin) and clariﬁ  ed by centrifugation. Mouse anti-FLAG 
antibody (M2; Sigma-Aldrich), rabbit anti-xB23, nonspeciﬁ  c mouse IgG, or 
nonspeciﬁ  c rabbit IgG were added to aliquots of the clariﬁ  ed supernatant 
and incubated for 1 h on ice before addition of 15   μ  l of preblocked protein 
G  –  Sepharose (GE Healthcare). After 1 h at 4  °  C with rotation, the beads 
were pelleted, washed with buffer A plus 0.00001% digitonin, and eluted 
with 25   μ  l of 0.1 M glycine, pH 2.3. 
  In   Fig. 1 C  , interphase XEEs were depleted using protein A Dynabeads 
coupled with anti-xB23/nucleophosmin antibodies or mock treated with rab-
bit IgG-coupled control beads. Resultant XEEs were supplemented with prote-
ase inhibitors and 20   μ  M Ran-Q69L, and immunoprecipitations with 
anti-xSENP3 antibody or rabbit IgG were performed as described in the pre-
vious paragraph. Bound proteins were eluted with 0.1 M glycine, pH 2.3. 
  In all cases, equal elution volumes were subjected to SDS-PAGE and 
Western blotting. In   Fig. 1  , protein A  –  HRP was used for visualization of 
xSENP3. Anti-mouse IgG  –  HRP was used for FLAG epitope visualization. 
Anti-rabbit HRP was used for visualization of all other antibodies. 
  Immunoﬂ  uorescence microscopy and Western blotting 
  Cells were grown on LabTeckII coverslip-bottomed chambers or glass slide 
coverslips. 72 h after transfection with siRNAs, cells were ﬁ  xed for 5 min 
with 4% formaldehyde in PBS and permeabilized for 5 min with 0.5% 
Triton X-100 in PBS. The cells were blocked for 1 h in PBS containing 1% bo-
vine serum albumin. After washing with PBS, the cells were incubated with 
primary antibodies diluted 1:200 in blocking solution for 1 h. The cover-
slips were washed and incubated for 1 h with AlexaFluor 488  –  conjugated 
  Haindl et al. (2008)  , but suspect that the relatively low levels of 
His-tagged SUMO proteins expressed in our stable cell lines may 
mimic physiological conditions more closely than conditions of 
transient expression. In any case, our results do not suggest that 
B23/nucleophosmin is itself the primary target of SENP3 or 
SENP5. As an alternative model, we note that B23/nucleophosmin 
interacts with ribosomes ( Grisendi et al., 2006 ), so that it might act 
as an adaptor for targeting of SUMO proteases to ribosomal pro-
teins. Consistent with this idea, 60S ribosomal components Rpl26 
and RplP0 are coprecipitated from XEEs with xSENP3 in a xB23/
nucleophosmin-dependent manner (  Fig. 1 C  ). 
  The requirement for B23/nucleophosmin in ribosome syn-
thesis has been proposed to include both action as an endonucle-
ase (  Savkur and Olson, 1998  ) and as a chaperone (  Szebeni and 
Olson, 1999  ). Our data show that regulation of SUMOylation 
through SENP3 and SENP5 is another major aspect of B23/
nucleophosmin function in this process. The capacity of xB23/
nucleophosmin to link xSENP3 with ribosomes suggests that it 
may recruit SUMO proteases to maturing ribosomal particles. Inter-
estingly, B23/nucleophosmin has been implicated in a variety of 
apparently unrelated cellular processes (  Grisendi et al., 2006  ), 
many of which are also dependent on the SUMO conjugation 
(  Hay, 2005  ). We therefore speculate that altered SUMOylation 
may be a simple, unifying mechanism that underlies much of the 
apparent plurality of B23/nucleophosmin functions. 
  Materials and methods 
  Chemicals and reagents 
  Human testis QUICK-Clone cDNA, human multiple tissue cDNAs, pEGFP, 
and pDsRed were obtained from Clontech Laboratories, Inc. Oligofectamine, 
Rabbit IgG tricolor labeling kit, and geneticin were obtained from Invitro-
gen. siRNA oligonucleotides (SENP1, AATCCTTCCTCAGACAGTTTT; SENP2, 
AACATGCTGAAACTGGGTAAT; SENP3, AAACTCCGTACCAAGGGTTAT; 
SENP5, AAGTCCACTGGTCTCTCATTA; control, AACTGTCAGTCAGTC-
GTAGTA), Ni-NTA agarose, and Effectene were obtained from QIAGEN. 
NHS-Sepharose, protein A  –  Sepharose, and HRP-conjugated secondary 
antibody were obtained from GE Healthcare. Mouse monoclonal anti-
B23/nucleophosmin and anti-UBF antibodies were from Santa Cruz Bio-
technology, Inc. Mouse monoclonal anti-GFP (JL-8) and rabbit anti-GFP (A.v) 
antibodies were obtained from BD and were used for Western blotting 
and immunoprecipitation, respectively. Mouse monoclonal anti-actin anti-
bodies were obtained from Sigma-Aldrich. Rabbit anti-RPL37A and anti-
GNL2 antibodies were obtained from Abnova. Rabbit anti-NVL antibodies 
were obtained from Proteintech Group, Inc. Rabbit polyclonal antibodies 
against Rpl26 and RplP0 were purchased from Bethyl Laboratories, Inc. 
and Proteintech Group, Inc., respectively. Rabbit antibodies against 
SUMO-1 and SUMO-2/3 were as described previously (  Azuma et al., 
2003  ). Other reagents were obtained from Sigma-Aldrich unless other-
wise stated. 
  cDNA constructs 
  Human SENP3 and SENP5 complete coding sequences were ampliﬁ  ed 
from a testis cDNA library and subcloned into the XhoI  –  KpnI or HindIII  –
  BamHI sites of pEGFP-C3, respectively. Full-length human ﬁ  brillarin  and 
B23/nucleophosmin cDNAs were ampliﬁ   ed from a testis cDNA library 
and subcloned into the SalI  –  BamHI and XhoI  –  HindIII sites of pCMV-DsRed-
Express vector, respectively. Full-length xSENP3 cDNA was obtained from 
American Type Culture Collection (IMAGE: 5155254). A full-length xSENP5 
cDNA was ampliﬁ  ed from a tadpole cDNA library and subcloned into the 
XhoI  –  SpeI sites of pT7-FLAG-TR     (a gift of Y.-B. Shi, National Institutes of 
Health, Bethesda, MD). This construct (pT7-FLAG-TR    -XSENP5) was used 
for FLAG-tagged xSENP5 expression. 
  Antibodies and immunological methods 
  Human SENP3 (amino acids 204  –  406) and SENP5 (amino acids 1  –  237) 
fragments were subcloned into the BamHI  –  XhoI sites and BamHI  –  SalI sites 595 B23/NUCLEOPHOSMIN REGULATES SENP3 AND SENP5   • Yun et al. 
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goat anti  –  rabbit or AlexaFluor 568  –  conjugated goat anti  –  mouse second-
ary antibodies (Invitrogen) diluted 1:500 in blocking solution. All the incu-
bations were performed at 23  °  C. After antibody incubations, the cells were 
washed twice with PBS and Hoechst 33258 was added to the ﬁ  nal wash-
ing solution for 1 min to stain the DNA. Coverslips were mounted in Vecta-
shield (Vector Laboratories). Fluorescence images were captured using a 
confocal microscope (LSM510 META; Carl Zeiss, Inc.) equipped with a 40  ×   
Plan Neoﬂ  uar objective, with confocal microscopy software (SP2 version 
3.2; Carl Zeiss, Inc.). Images were analyzed using Photoshop 7.0 (Adobe). 
Western blotting was performed using standard protocols (  Gallagher et al., 
1998  ). Unless otherwise indicated, all antibodies were used at a dilution 
of 1:2,000 for Western blotting. Electrophoretic migration of bands in all 
Western blots are indicated with respect to molecular mass standards run 
on the same SDS-PAGE gels. 
  Metabolic labeling and analysis of [ 
3  H]uridine-labeled RNA 
  72 h after transfection with SENP3 or SENP5 siRNAs, HeLa cells were 
pulsed in DME containing [ 
3  H]uridine (10   μ  Ci/ml) for 25 min, and then 
chased in nonradioactive media for the indicated times in the presence of 
1 mg/ml of cold uridine (EMD). At each point, the same number of cells 
was harvested. Total RNA was extracted with Trizol reagent (Invitrogen) 
and suspended with diethylpyrocarbonate-treated water. Formaldehyde 
loading dye (Applied Biosystems) was added before heat treatment at 
65  °  C for 45 min. RNAs were separated on a 1% agarose-denaturing gel 
containing 0.55 M formaldehyde. Formaldehyde was removed by wash-
ing with water for 40 min, and the gel was treated with 7.5 mM NaOH 
to hydrolyze the RNA. After soaking the gel within 20  ×   SSC buffer for 
45 min, the RNA was transferred to a nylon membrane (GE Healthcare) 
overnight. After transfer, RNA was cross-linked to the membrane with UV 
light. The membrane was dried, sprayed by EN 
3  HANCE (PerkinElmer), and 
exposed to BioMax XAR ﬁ  lm (Kodak) at     80  °  C. 
  Online supplemental material 
  Fig. S1 shows the quantitation of SUMO redistribution after SENP3, 
SENP5, and B23/nucleophosmin depletion. Fig. S2 shows SENP3 and 
SENP5 paralogue preferences and expression patterns. Fig. S3 shows mis-
localization of ribosomal processing factor NVL2 in the absence of SENP3 
and SENP5. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200807185/DC1. 
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